|
|
Article: Study: Asthma Treatment Helped Reduce Dose of Inhaled Corticosteroids While Maintaining Asthma Control; Study Found That Patients on Advair Diskus(R) (Fluticasone Propionate and Salmeterol Inhalation Powder) 100/50 BID Maintained Asthma Control Compared with Fluticasone Propionate 250 mcg BID Alone, at 60 Percent Reduction in Inhaled Corticosteroid Dose.
- Article from:
- PR Newswire
- Article date:
- November 6, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO -- An asthma treatment that contains both an inhaled long-acting bronchodilator and an inhaled corticosteroid was as effective at providing overall asthma control as more than double the dose of the inhaled corticosteroid alone, according to a study presented today at CHEST 2002, the annual scientific meeting of the American College of Chest Physicians.
This "inhaled corticosteroid-sparing" effect is an important consideration in asthma therapy. According to asthma treatment guidelines issued by the National Institutes of Health, inhaled corticosteroids are the most effective long-term-control medications available for the treatment of asthma.(1) Though ...